In most cases, the standard treatment for early-stage breast cancer is lumpectomy to remove the cancer followed by about 6 weeks of radiation therapy (5 days a week) to destroy any cancer cells that may have been left behind. This two-step approach reduces the risk of breast cancer recurrence (the cancer coming back).
Doctors have wondered if women diagnosed with early-stage disease with a low risk of recurrence need radiation treatment to the whole breast, which is the current standard of care. Or could these early-stage cancers with a low risk of recurrence be treated with radiation just to the area around where the cancer used to be?
Five-year results from a U.K. study suggest that treating just the area around where the cancer used to be with radiation may be as good as treating the whole breast with radiation.
The research was published on Sept. 9, 2017 by The Lancet. Read “Partial-breast radiotherapy after breast conservaton surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicenter, randomised, controlled, phase 3, non-inferiority trial.”
The study included 2,016 women age 50 or older who had been diagnosed with early-stage breast cancer between 2007 and 2010. All the cancers were 3 cm or smaller, and all the women had three or fewer positive lymph nodes. All the women had lumpectomy to remove the breast cancer.
After surgery, the women were randomly assigned to one of three radiation regimens:
- 674 women had the standard full dose of 40 Gy of radiation to the whole breast
- 673 women had 40 Gy of radiation to the tumor bed and 36 Gy to the rest of the breast
- 669 women had 40 Gy to the tumor bed only
A Gray, abbreviated Gy, is the way radiation oncologists measure the dose of radiation therapy.
"We considered it important to set up a trial to answer the question: is full dose radiotherapy to the whole breast needed in patients with low-risk early breast cancer?" said Charlotte Coles, M.D., consultant clinical oncologist at Cambridge University Hospitals. "One group of women received standard full dose radiotherapy to the whole breast. A second group received standard full dose to breast tissue closest to where the lump appears and a slightly lower dose further away. A third group received standard full dose radiotherapy to breast tissue closest to where the lump appears but no radiotherapy dose apart from this."
After 5 years of follow-up, local recurrence rates (breast cancer coming back in the same breast) were:
- 1.1% for women who got the standard dose of radiation
- 0.2% for women who got the full dose of radiation to the area where the cancer was and a slightly lower dose further away
- 0.5% for women who got the standard full dose of radiation only to the area where the cancer was
"We found after 5 years that rates of local relapse (the reappearance of a cancer after treatment in the breast where it was originally detected) were very low in all treatment groups, including those receiving less radiotherapy. Moderate and marked changes in normal breast tissue were also low across all groups," Dr. Coles said. "However, we intend to continue to follow up the trial patients for at least 10 years because we know that cancer recurrence can still occur more than 5 years after completion of treatment. It may be that no dose outside the tumor bed is sufficient for many patients, but some dose at a lower level than that given to the tumor bed is more appropriate for others."
"This is a good preliminary look at an important question for which randomized data between whole and partial breast radiation is just emerging," said Marisa Weiss, M.D., Breastcancer.org chief medical officer and director of breast radiation oncology at Lankenau Medical Center. "We need longer follow-up to really know how these treatment regimens compare. We also need other trials to report their results."
While these results are very promising, they are still early results. Doctors need longer follow-up information to see whether radiation to just the area where the cancer was offers the same local recurrence rates 7, 9, or 10 years after treatment. Low-risk cancers are slow-growing by nature, so they can come back many years after treatment. This is especially important for women who are diagnosed at a relatively younger age and have many years of life ahead of them.
For more information, visit the Breastcancer.org Radiation Therapy section.
Can we help guide you?
Create a profile for better recommendations
Breast self-exam, or regularly examining your breasts on your own, can be an important way to...
Eating When You Have Nausea and Vomiting
Almost all breast cancer treatments have varying degrees of risk for nausea and vomiting. Some...
Tamoxifen (Brand Names: Nolvadex, Soltamox)
Tamoxifen is the oldest and most-prescribed selective estrogen receptor modulator (SERM)....